ASKA Pharmaceutical Holdings Co.,Ltd. [4886.T]
TOKYO, May 25 (Pulse News Wire) – Aska Pharmaceutical Holdings CO.,LTD. (4886.T) decided on May 25 to appoint EY Shin Nihon LLC as its new auditor, effective June 24, 2026, prior to its fifth regular shareholders' meeting scheduled for the same day.
The move follows the expiration of the term of the incumbent auditor, Seio Audit Corporation, which was appointed on June 29, 2011. The board of directors chose EY Shin Nihon LLC due to its ability to bring fresh perspectives to audits and its suitability for aligning with ASKA's group-wide business strategies and unified audit systems. Additionally, the firm demonstrated expertise, independence, and robust quality control measures, making it well-suited for the role.
Seio Audit Corporation completed its tenure without issuing any adverse opinions in recent years. However, considering the need for fresh viewpoints and the continuity of auditing standards within the group, ASKA opted for a change. Both the outgoing auditor and the board of auditors concurred with the decision.
🟢 Confidence: High AI-translated content.